ZXDC expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.6937120029279E-13 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.73283609683494E-12 |
Normal-vs-Stage2 |
3.795100E-03 |
Normal-vs-Stage3 |
1.7722999999914E-05 |
Normal-vs-Stage4 |
1.19529941500218E-11 |
Stage1-vs-Stage2 |
5.923200E-01 |
Stage1-vs-Stage3 |
8.938800E-01 |
Stage1-vs-Stage4 |
6.017900E-02 |
Stage2-vs-Stage3 |
6.270800E-01 |
Stage2-vs-Stage4 |
3.233600E-02 |
Stage3-vs-Stage4 |
4.038400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.90618656812103E-12 |
Normal-vs-AfricanAmerican |
4.46209957871702E-10 |
Normal-vs-Asian |
4.71290000358948E-08 |
Caucasian-vs-AfricanAmerican |
3.093000E-01 |
Caucasian-vs-Asian |
2.451800E-01 |
AfricanAmerican-vs-Asian |
3.908200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.38888900380607E-13 |
Normal-vs-Female |
5.16129999961201E-07 |
Male-vs-Female |
2.726200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.17079999975667E-07 |
Normal-vs-Extreme_Weight |
2.14284145982901E-12 |
Normal-vs-Obese |
2.16729999946708E-07 |
Normal-vs-Extreme_Obese |
1.143830E-02 |
Normal_Weight-vs-Extreme_Weight |
7.062000E-01 |
Normal_Weight-vs-Obese |
4.443000E-01 |
Normal_Weight-vs-Extreme_Obese |
7.672800E-01 |
Extreme_Weight-vs-Obese |
1.734170E-01 |
Extreme_Weight-vs-Extreme_Obese |
5.748800E-01 |
Obese-vs-Extreme_Obese |
8.769600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.101200E-03 |
Normal-vs-Age(41-60Yrs) |
1.01829999987757E-09 |
Normal-vs-Age(61-80Yrs) |
9.19930798204405E-13 |
Normal-vs-Age(81-100Yrs) |
2.619300E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.954000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.711600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.285600E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.053200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.220990E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.588200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.54619994585659E-09 |
Normal-VS-Type2 PRCC |
1.22124532708767E-15 |
Normal-VS-KIRP CIMP |
1.295860E-02 |
Normal-VS-Unclassified PRCC |
9.790100E-04 |
Type1 PRCC-VS-Type2 PRCC |
2.375700E-04 |
Type1 PRCC-VS-KIRP CIMP |
7.315400E-01 |
Type1 PRCC-VS-Unclassified PRCC |
7.803400E-01 |
Type2 PRCC-VS-KIRP CIMP |
1.724780E-01 |
Type2 PRCC-VS-Unclassified PRCC |
5.228000E-02 |
KIRP CIMP-VS-Unclassified PRCC |
8.921200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.30970798043018E-12 |
Normal-vs-N1 |
1.680170E-03 |
Normal-vs-N2 |
1.58920000492557E-08 |
N0-vs-N1 |
1.803210E-01 |
N0-vs-N2 |
1.442640E-01 |
N1-vs-N2 |
1.176240E-01 |
|
|